We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter |  ONLINE FIRST
Stephen Thielke, MD, MS, MA; Christopher G. Slatore, MD, MS; William A. Banks, MD
JAMA Psychiatry. Published online October 21, 2015. doi:10.1001/jamapsychiatry.2015.1852

Original Investigation | 
David Pagliaccio, PhD; Deanna M. Barch, PhD; Ryan Bogdan, PhD; et al.
JAMA Psychiatry. 2015;72(10):994-1001. doi:10.1001/jamapsychiatry.2015.1054.
Includes: Supplemental Content

Original Investigation | 
Bradley S. Peterson, MD; Virginia A. Rauh, ScD; Ravi Bansal, PhD; et al.
JAMA Psychiatry. 2015;72(6):531-540. doi:10.1001/jamapsychiatry.2015.57.
Includes: Supplemental Content

Viewpoint | 
Lilian Calderón-Garcidueñas, MA, MD, PhD; Ricardo Torres-Jardón, PhD
JAMA Psychiatry. 2015;72(6):529-530. doi:10.1001/jamapsychiatry.2015.0192.

Editorial | 
Donald C. Goff, MD
JAMA Psychiatry. 2014;71(6):621-622. doi:10.1001/jamapsychiatry.2014.257.

Perspectives | 
Daniel R. Weinberger, MD; Robert K. McClure, MD
Arch Gen Psychiatry. 2002;59(6):553-558. doi:10.1001/archpsyc.59.6.553.

Commentary | 
Una D. McCann, MD; George A. Ricaurte, MD, PhD; Mark E. Molliver, MD
Arch Gen Psychiatry. 2001;58(10):907-908. doi:10.1001/archpsyc.58.10.907.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
Blood-Brain Barrier Permeability and Gadolinium Benefits and Potential Pitfalls in Research
Axel Montagne, PhD; Arthur W. Toga, PhD; Berislav V. Zlokovic, MD, PhD
JAMA Neurology
Research Letter  | 
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis
Bardia Nourbakhsh, MD; Nisha Revirajan, MD; Emmanuelle Waubant, MD, PhD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.